Attached files
| file | filename |
|---|---|
| 8-K - FORM 8K BARCLAYS CAPITAL - WEST PHARMACEUTICAL SERVICES INC | form8k.htm |
| EX-99.2 - PRESENTATION SLIDES - WEST PHARMACEUTICAL SERVICES INC | slides.htm |
Exhibit 99.1
|
Contacts:
West Pharmaceutical Services, Inc.
Michael A. Anderson
Vice President and Treasurer
(610) 594-3345 |
Investors and Financial Media:
Westwicke Partners
John Woolford/Stefan Loren
(443) 213-0506/0507 |
West to Present at Barclays Investor Conference
LIONVILLE, Pa., March 17, 2010 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, and William Federici, Chief Financial Officer, will attend the Barclays Capital 2010 Global Healthcare Conference in Miami, FL. Management will present an
overview of West's business and outlook on Wednesday, March 24, 2010 at 2:30 PM ET.
A copy of the corporate presentation document as well as a live audio webcast of the presentations will be posted on the investor link of the Company's website at www.westpharma.com.
About West
West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville,
Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.